Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem—Are We Ready for a Revolution?
The pace of scientific progress over the past several decades within the biological, drug development, and the digital realm has been remarkable. The’omics revolution has enabled a better understanding of the biological basis of disease, unlocking the possibility of new products such as gene and cel...
Main Authors: | Judith C. Macdonald, David C. Isom, Daniel D. Evans, Katy J. Page |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.660808/full |
Similar Items
-
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
by: Serena Brancati, et al.
Published: (2021-07-01) -
Proving the Applicability of the Theory of Regulation and the Economic Theory of Regulatory Constraint to American Indian Studies (AIS): A Case Study in Federal Indian Law and Policy
by: Weinzettle, Christina
Published: (2010) -
Sketching an AI Marketplace: Tech, Economic, and Regulatory Aspects
by: Abhishek Kumar, et al.
Published: (2021-01-01) -
Utilization of risk-based predictive stability within regulatory submissions; industry’s experience
by: Megan McMahon, et al.
Published: (2020-05-01) -
IMO’s Marine Environmental Regulatory Governance and China’s Role: An Empirical Study of China’s Submissions
by: Jiayu Bai, et al.
Published: (2021-09-01)